Publication | Closed Access

Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineBiological NetworkComputational BiologyNeurochemical BiomarkersRegulatory Network ModellingPathway AnalysisNeuroscienceMolecular SignaturesBiological Network VisualizationPharmacologyDrug DiscoveryTherapeutic AgentsNetwork-based Approach